Neurocritical Care

, Volume 18, Issue 1, pp 118–130 | Cite as

Influenza-Associated Neurological Complications

Review Article

Abstract

While mostly diagnosed in the pediatric population, neurological complications of pandemic influenza A infection may affect young and previously healthy adults, and may follow a fulminant, severe, and occasionally fatal course. We reviewed severe neurological complications secondary to influenza infection reported in the literature, in attempt to outline recurrent syndromes that may assist the clinician in making a timely diagnosis. Vigilance and awareness of these clinical entities are key in the neurologist and intensivist’s role in surveillance and early recognition of pandemic influenza, and in ensuring improved survival for affected patients.

Keywords

Influenza Influenza vaccine Encephalopathy Brain edema H1N1 Coma 

References

  1. 1.
    Agyeman P, Duppenthaler A, Heininger U, Aebi C. Influenza-associated myositis in children. Infection. 2004;32(4):199–203.PubMedCrossRefGoogle Scholar
  2. 2.
    Aiba H, Mochizuki M, Kimura M, Hojo H. Predictive value of serum interleukin-6 level in influenza virus-associated encephalopathy. Neurology. 2001;57(2):295–9.PubMedCrossRefGoogle Scholar
  3. 3.
    Akins PT, Belko J, Uyeki TM, Axelrod Y, Lee KK, Silverthorn J. H1N1 encephalitis with malignant edema and review of neurologic complications from influenza. Neurocrit Care. 2010;13(3):396–406.PubMedCrossRefGoogle Scholar
  4. 4.
    Amin R, Ford-Jones E, Richardson SE, MacGregor D, Tellier R, Heurter H, Fearon M, Bitnun A. Acute childhood encephalitis and encephalopathy associated with influenza: a prospective 11 year review. Pediatr Infect Dis J. 2008;27(5):390–5.PubMedCrossRefGoogle Scholar
  5. 5.
    Auriel E, Gadoth A, Regev K, et al. Seasonal and H1N1v influenza vaccines in MS: safety and compliance. J Neurol Sci. 2012;314(1–2):102–3.PubMedCrossRefGoogle Scholar
  6. 6.
    Bacon CJ, Hall SM. Haemorrhagic shock encephalopathy syndrome in the British Isles. Arch Dis Child. 1992;67(8):985–93.PubMedCrossRefGoogle Scholar
  7. 7.
    Bardage C, Persson I, Ortgvist A, et al. Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm. Sweden BMJ. 2011;343:d5956.CrossRefGoogle Scholar
  8. 8.
    Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, Zaki SR, Hayden FG, Hui DS, Kettner JD, et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med. 2010;362(18):1708–19.PubMedCrossRefGoogle Scholar
  9. 9.
    Berger JR, Houff SA. Neurological infections: the year of PML and influenza. Lancet Neurol. 2010;9(1):14–7.PubMedCrossRefGoogle Scholar
  10. 10.
    Black S, Eskola J, Siegrist CA, Halsey N, Macdonald N, Law B, Miller E, Andrews N, Stowe J, Salmon D, et al. Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines. Lancet. 2009;374(9707):2115–22.PubMedCrossRefGoogle Scholar
  11. 11.
    Chen YC, Lo CP, Chang TP. Novel influenza A (H1N1)-associated encephalopathy/encephalitis with severe neurological sequelae and unique image features–a case report. J Neurol Sci. 2010;298(1–2):110–3.PubMedCrossRefGoogle Scholar
  12. 12.
    Davis LE. Neurologic and muscular complications of the 2009 influenza A (H1N1) pandemic. Curr Neurol Neurosci Rep. 2010;10(6):476–83.PubMedCrossRefGoogle Scholar
  13. 13.
    de Jong MD, Bach VC, Phan TQ, Vo MH, Tran TT, Nguyen BH, Beld M, Le TP, Truong HK, Nguyen VV, et al. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med. 2005;352(7):686–91.PubMedCrossRefGoogle Scholar
  14. 14.
    de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med. 2006;12(10):1203–7.PubMedCrossRefGoogle Scholar
  15. 15.
    Destefano F, Tokars J. H1N1 vaccine safety monitoring: beyond background rates. Lancet. 2010;375(9721):1146–7.PubMedCrossRefGoogle Scholar
  16. 16.
    Drago L, Attia MW, DePiero A, Bean C. Influenza A-associated meningoencephalitis. Pediatr Emerg Care. 2005;21(7):437–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Eisen DP, McBryde ES. Avoiding Guillan-Barre Syndrome following swine origin pandemic H1N1 2009 influenza vaccination. J Infect Dis. 2009;200(10):1627–8.PubMedCrossRefGoogle Scholar
  18. 18.
    Evans D, Cauchemez S, Hayden FG. “Prepandemic” immunization for novel influenza viruses, “swine flu” vaccine, Guillain-Barre syndrome, and the detection of rare severe adverse events. J Infect Dis. 2009;200(3):321–8.PubMedCrossRefGoogle Scholar
  19. 19.
    Finsterer J, Artner C, Kladosek A, Kalchmayr R, Redtenbacher S. Cavernous sinus syndrome due to vaccination-induced giant cell arteritis. Arch Intern Med. 2001;161(7):1008–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Fluss J, Ferey S, Menache-Starobinski C, Delavelle J, Van Bogaert P, Vargas MI. Mild influenza-associated encephalopathy/encephalitis with a reversible splenial lesion in a Caucasian child with additional cerebellar features. Eur J Paediatr Neurol. 2010;14(1):97–100.PubMedCrossRefGoogle Scholar
  21. 21.
    Foley PB. Encephalitis lethargica and the influenza virus. II. The influenza pandemic of 1918/19 and encephalitis lethargica: epidemiology and symptoms. J Neural Transm. 2009;116(10):1295–308.PubMedCrossRefGoogle Scholar
  22. 22.
    Foley PB. Encephalitis lethargica and the influenza virus. III. The influenza pandemic of 1918/19 and encephalitis lethargica: neuropathology and discussion. J Neural Transm. 2009;116(10):1309–21.PubMedCrossRefGoogle Scholar
  23. 23.
    Fugate JE, Lam EM, Rabinstein AA, Wijdicks EF. Acute hemorrhagic leukoencephalitis and hypoxic brain injury associated with H1N1 influenza. Arch Neurol. 2010;67(6):756–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Fujimoto S, Kobayashi M, Uemura O, Iwasa M, Ando T, Katoh T, Nakamura C, Maki N, Togari H, Wada Y. PCR on cerebrospinal fluid to show influenza-associated acute encephalopathy or encephalitis. Lancet. 1998;352(9131):873–5.PubMedCrossRefGoogle Scholar
  25. 25.
    Ganapathy S, Ey EH, Wolfson BJ, Khan N. Transient isolated lesion of the splenium associated with clinically mild influenza encephalitis. Pediatr Radiol. 2008;38(11):1243–5.PubMedCrossRefGoogle Scholar
  26. 26.
    Gefen R, Eshel G, Abu-Kishk I, Lahat E, Youngster I, Rosenbloom E, Kozer E. Hemorrhagic shock and encephalopathy syndrome: clinical course and neurological outcome. J Child Neurol. 2008;23(5):589–92.PubMedCrossRefGoogle Scholar
  27. 27.
    Gika AD, Rich P, Gupta S, Neilson DE, Clarke A. Recurrent acute necrotizing encephalopathy following influenza A in a genetically predisposed family. Dev Med Child Neurol. 2010;52(1):99–102.PubMedCrossRefGoogle Scholar
  28. 28.
    Gooskens J, Kuiken T, Claas EC, Harinck HI, Thijssen JC, Baelde HJ, Kroes AC. Severe influenza resembling hemorrhagic shock and encephalopathy syndrome. J Clin Virol. 2007;39(2):136–40.PubMedCrossRefGoogle Scholar
  29. 29.
    Hidaka F, Matsuo S, Muta T, Takeshige K, Mizukami T, Nunoi H. A missense mutation of the Toll-like receptor 3 gene in a patient with influenza-associated encephalopathy. Clin Immunol. 2006;119(2):188–94.PubMedCrossRefGoogle Scholar
  30. 30.
    Honorat R, Tison C, Sevely A, et al. Influenza A(H1N1)-associated ischemic stroke in a 9-month-old child. Pediatr Emerg Care. 2012;28(4):368–9.PubMedCrossRefGoogle Scholar
  31. 31.
    Hosoya M, Kawasaki Y, Katayose M, Sakuma H, Watanabe M, Igarashi E, Aoyama M, Nunoi H, Suzuki H. Prognostic predictive values of serum cytochrome c, cytokines, and other laboratory measurements in acute encephalopathy with multiple organ failure. Arch Dis Child. 2006;91(6):469–72.PubMedCrossRefGoogle Scholar
  32. 32.
    Hosoya M, Nunoi H, Aoyama M, Kawasaki Y, Suzuki H. Cytochrome c and tumor necrosis factor-alpha values in serum and cerebrospinal fluid of patients with influenza-associated encephalopathy. Pediatr Infect Dis J. 2005;24(5):467–70.PubMedCrossRefGoogle Scholar
  33. 33.
    Huang YC, Lin TY, Wu SL, Tsao KC. Influenza A-associated central nervous system dysfunction in children presenting as transient visual hallucination. Pediatr Infect Dis J. 2003;22(4):366–8.PubMedGoogle Scholar
  34. 34.
    Hull JH, Mead SH, Foster OJ, Modarres-Sadeghi H. Severe vasculitic neuropathy following influenza vaccination. J Neurol Neurosurg Psychiatry. 2004;75(10):1507–8.PubMedCrossRefGoogle Scholar
  35. 35.
    Huynh W, Cordato DJ, Kehdi E, Masters LT, Dedousis C. Post-vaccination encephalomyelitis: literature review and illustrative case. J Clin Neurosci. 2008;15(12):1315–22.PubMedCrossRefGoogle Scholar
  36. 36.
    Ichiyama T, Isumi H, Ozawa H, Matsubara T, Morishima T, Furukawa S. Cerebrospinal Fluid and Serum Levels of Cytokines and Soluble Tumor Necrosis Factor Receptor in Influenza Virus-associated Encephalopathy. Scand J Infect Dis. 2003;35(1):59–61.PubMedCrossRefGoogle Scholar
  37. 37.
    Ichiyama T, Morishima T, Kajimoto M, Matsushige T, Matsubara T, Furukawa S. Matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in influenza-associated encephalopathy. Pediatr Infect Dis J. 2007;26(6):542–4.PubMedCrossRefGoogle Scholar
  38. 38.
    Ichiyama T, Morishima T, Suenaga N, Kajimoto M, Matsubara T, Furukawa S. Analysis of serum soluble CD40 ligand in patients with influenza virus-associated encephalopathy. J Neurol Sci. 2005;239(1):53–7.PubMedCrossRefGoogle Scholar
  39. 39.
    Ishigami A, Kubo S, Ikematsu K, Kitamura O, Tokunaga I, Gotohda T, Nakasono I. An adult autopsy case of acute encephalopathy associated with influenza A virus. Leg Med (Tokyo). 2004;6(4):252–5.CrossRefGoogle Scholar
  40. 40.
    Ito Y, Ichiyama T, Kimura H, Shibata M, Ishiwada N, Kuroki H, Furukawa S, Morishima T. Detection of influenza virus RNA by reverse transcription-PCR and proinflammatory cytokines in influenza-virus-associated encephalopathy. J Med Virol. 1999;58(4):420–5.PubMedCrossRefGoogle Scholar
  41. 41.
    Iwata A, Matsubara K, Nigami H, Kamimura K, Fukaya T. Reversible splenial lesion associated with novel influenza A (H1N1) viral infection. Pediatr Neurol. 2010;42(6):447–50.PubMedCrossRefGoogle Scholar
  42. 42.
    Juurlink DN, Stukel TA, Kwong J, Kopp A, McGeer A, Upshur RE, Manuel DG, Moineddin R, Wilson K. Guillain-Barre syndrome after influenza vaccination in adults: a population-based study. Arch Intern Med. 2006;166(20):2217–21.PubMedCrossRefGoogle Scholar
  43. 43.
    Kao CD, Chen JT, Lin KP, Shan DE, Wu ZA, Liao KK. Guillain-Barre syndrome coexisting with pericarditis or nephrotic syndrome after influenza vaccination. Clin Neurol Neurosurg. 2004;106(2):136–8.PubMedCrossRefGoogle Scholar
  44. 44.
    Kasai T, Togashi T, Morishima T. Encephalopathy associated with influenza epidemics. Lancet. 2000;355(9214):1558–9.PubMedCrossRefGoogle Scholar
  45. 45.
    Kawada J, Kimura H, Hara S, Ito Y, Kawashima H, Okuno T, Morishima T. Absence of associations between influenza-associated encephalopathy and human herpesvirus 6 or human herpesvirus 7. Pediatr Infect Dis J. 2003;22(2):115–9.PubMedGoogle Scholar
  46. 46.
    Kawada J, Kimura H, Ito Y, Hara S, Iriyama M, Yoshikawa T, Morishima T. Systemic cytokine responses in patients with influenza-associated encephalopathy. J Infect Dis. 2003;188(5):690–8.PubMedCrossRefGoogle Scholar
  47. 47.
    Kawashima H, Togashi T, Yamanaka G, Nakajima M, Nagai M, Aritaki K, Kashiwagi Y, Takekuma K, Hoshika A. Efficacy of plasma exchange and methylprednisolone pulse therapy on influenza-associated encephalopathy. J Infect. 2005;51(2):E53–6.PubMedCrossRefGoogle Scholar
  48. 48.
    Kawashima H, Watanabe Y, Ichiyama T, Mizuguchi M, Yamada N, Kashiwagi Y, Takekuma K, Hoshika A, Mori T. High concentration of serum nitrite/nitrate obtained from patients with influenza-associated encephalopathy. Pediatr Int. 2002;44(6):705–7.PubMedCrossRefGoogle Scholar
  49. 49.
    Kawashima H, Watanabe Y, Morishima T, Togashi T, Yamada N, Kashiwagi Y, Takekuma K, Hoshika A, Mori T. NOx (nitrite/nitrate) in cerebral spinal fluids obtained from patients with influenza-associated encephalopathy. Neuropediatrics. 2003;34(3):137–40.PubMedCrossRefGoogle Scholar
  50. 50.
    Kostianovsky A, Charles P, Alves JF, et al. Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patients. Clin Exp Rheumatol. 2012;30(1 Suppl 70):S83–9.PubMedGoogle Scholar
  51. 51.
    Lee N. Acute Encephalopathy Associated with Influenza A Infection in Adults. Emerging Infectious Diseases 2010;16(1).Google Scholar
  52. 52.
    Lehmann HC, Hartung HP, Kieseier BC, Hughes RA. Guillain-Barre syndrome after exposure to influenza virus. Lancet Infect Dis. 2010;10(9):643–51.PubMedCrossRefGoogle Scholar
  53. 53.
    Lyon JB, Remigio C, Milligan T, Deline C. Acute necrotizing encephalopathy in a child with H1N1 influenza infection. Pediatr Radiol. 2010;40(2):200–5.PubMedCrossRefGoogle Scholar
  54. 54.
    Martin A, Reade EP. Acute necrotizing encephalopathy progressing to brain death in a pediatric patient with novel influenza A (H1N1) infection. Clin Infect Dis. 2010;50(8):e50–2.PubMedCrossRefGoogle Scholar
  55. 55.
    Maurizi CP. Influenza caused epidemic encephalitis (encephalitis lethargica): the circumstantial evidence and a challenge to the nonbelievers. Med Hypotheses. 2010;74(5):798–801.PubMedCrossRefGoogle Scholar
  56. 56.
    Mizuguchi M. Acute necrotizing encephalopathy of childhood: a novel form of acute encephalopathy prevalent in Japan and Taiwan. Brain Dev. 1997;19(2):81–92.PubMedCrossRefGoogle Scholar
  57. 57.
    Mizuguchi M, Yamanouchi H, Ichiyama T, Shiomi M. Acute encephalopathy associated with influenza and other viral infections. Acta Neurol Scand. 2007;115(4 Suppl):45–56.PubMedCrossRefGoogle Scholar
  58. 58.
    Moro PL, Tepper NK, Grohskopf LA, et al. Safety of seasonal influenza and influenza A (H1N1) 2009 monovalent vaccines in pregnancy. Expert Rev Vaccines. 2012;11(8):911–21.PubMedCrossRefGoogle Scholar
  59. 59.
    Mortimer PP. Was encephalitis lethargica a post-influenzal or some other phenomenon? Time to re-examine the problem. Epidemiol Infect. 2009;137(4):449–55.PubMedCrossRefGoogle Scholar
  60. 60.
    Muhammad S, Haasbach E, Kotchourko M, Strigli A, Krenz A, Ridder DA, Vogel AB, Marti HH, Al-Abed Y, Planz O, et al. Influenza virus infection aggravates stroke outcome. Stroke. 2011;42(3):783–91.PubMedCrossRefGoogle Scholar
  61. 61.
    Nakamura N, Nokura K, Zettsu T, Koga H, Tachi M, Terada M, Katoh H, Itoh Y, Osawa H, Ozeki T, et al. Neurologic complications associated with influenza vaccination: two adult cases. Intern Med. 2003;42(2):191–4.PubMedCrossRefGoogle Scholar
  62. 62.
    Neurologic complications associated with novel influenza A (H1N1) virus infection in children - Dallas, Texas, May 2009. MMWR Morb Mortal Wkly Rep 2009, 58(28):773-778.Google Scholar
  63. 63.
    Newland JG, Laurich VM, Rosenquist AW, Heydon K, Licht DJ, Keren R, Zaoutis TE, Watson B, Hodinka RL, Coffin SE. Neurologic complications in children hospitalized with influenza: characteristics, incidence, and risk factors. J Pediatr. 2007;150(3):306–10.PubMedCrossRefGoogle Scholar
  64. 64.
    Ng WF, Chiu SC, Lam DS, Wong YC, Tam S, Kwong NS, Loo KT, Yuen KY. A 7-year-old boy dying of acute encephalopathy. Brain Pathol. 2010;20(1):261–4.PubMedCrossRefGoogle Scholar
  65. 65.
    Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med. 2003;348(14):1322–32.PubMedCrossRefGoogle Scholar
  66. 66.
    Nunoi H, Mercado MR, Mizukami T, Okajima K, Morishima T, Sakata H, Nakayama S, Mori S, Hayashi M, Mori H, et al. Apoptosis under hypercytokinemia is a possible pathogenesis in influenza-associated encephalopathy. Pediatr Int. 2005;47(2):175–9.PubMedCrossRefGoogle Scholar
  67. 67.
    Okabe N, Yamashita K, Taniguchi K, Inouye S. Influenza surveillance system of Japan and acute encephalitis and encephalopathy in the influenza season. Pediatr Int. 2000;42(2):187–91.PubMedCrossRefGoogle Scholar
  68. 68.
    Okumura A, Abe S, Kidokoro H, Mizuguchi M. Acute necrotizing encephalopathy: a comparison between influenza and non-influenza cases. Microbiol Immunol. 2009;53(5):277–80.PubMedCrossRefGoogle Scholar
  69. 69.
    Okumura A, Mizuguchi M, Kidokoro H, Tanaka M, Abe S, Hosoya M, Aiba H, Maegaki Y, Yamamoto H, Tanabe T, et al. Outcome of acute necrotizing encephalopathy in relation to treatment with corticosteroids and gammaglobulin. Brain Dev. 2009;31(3):221–7.PubMedCrossRefGoogle Scholar
  70. 70.
    Olgar S, Ertugrul T, Nisli K, Aydin K, Caliskan M. Influenza a-associated acute necrotizing encephalopathy. Neuropediatrics. 2006;37(3):166–8.PubMedCrossRefGoogle Scholar
  71. 71.
    Pandemic influenza: a priority for the neurological community. Lancet Neurol 2009; 8(10):869.Google Scholar
  72. 72.
    Parikh M, Dolson G, Ramanathan V, Sangsiraprapha W. Novel H1N1-associated rhabdomyolysis leading to acute renal failure. Clin Microbiol Infect. 2010;16(4):330–2.PubMedCrossRefGoogle Scholar
  73. 73.
    Partinen M, Saarenpaa-Heikkila O, Ilveskoski I, et al. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS ONE. 2012;7(3):33723.CrossRefGoogle Scholar
  74. 74.
    Perez C, Loza E, Tinture T. Giant cell arteritis after influenza vaccination. Arch Intern Med. 2000;160(17):2677.PubMedCrossRefGoogle Scholar
  75. 75.
    Preliminary results: surveillance for Guillain-Barre syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010. MMWR Morb Mortal Wkly Rep 2010, 59(21):657-661.Google Scholar
  76. 76.
    Reid AH, McCall S, Henry JM, Taubenberger JK. Experimenting on the past: the enigma of von Economo’s encephalitis lethargica. J Neuropathol Exp Neurol. 2001;60(7):663–70.PubMedGoogle Scholar
  77. 77.
    Ryan MM, Procopis PG, Ouvrier RA. Influenza A encephalitis with movement disorder. Pediatr Neurol. 1999;21(3):669–73.PubMedCrossRefGoogle Scholar
  78. 78.
    Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009. MMWR Morb Mortal Wkly Rep 2009, 58(48):1351-1356.Google Scholar
  79. 79.
    Sakurai T, Kimura A, Tanaka Y, Hozumi I, Ogura S, Inuzuka T. Case of adult influenza type A virus-associated encephalopathy successfully treated with primary multidisciplinary treatments. Rinsho Shinkeigaku. 2007;47(10):639–43.PubMedGoogle Scholar
  80. 80.
    Sanchez-Torrent L, Trivino-Rodriguez M, Suero-Toledano P, Claret-Teruel G, Munoz-Almagro C, Martinez-Sanchez L, Jordan-Garcia I, Garcia–Garcia JJ. Novel influenza A (H1N1) encephalitis in a 3-month-old infant. Infection. 2010;38(3):227–9.PubMedCrossRefGoogle Scholar
  81. 81.
    Sato S, Kumada S, Koji T, Okaniwa M. Reversible frontal lobe syndrome associated with influenza virus infection in children. Pediatr Neurol. 2000;22(4):318–21.PubMedCrossRefGoogle Scholar
  82. 82.
    Shieh WJ, Blau DM, Denison AM, Deleon-Carnes M, Adem P, Bhatnagar J, Sumner J, Liu L, Patel M, Batten B, et al. 2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am J Pathol. 2010;177(1):166–75.PubMedCrossRefGoogle Scholar
  83. 83.
    Shiomi M. Pathogenesis of acute encephalitis and acute encephalopathy. Nippon Rinsho. 2011;69(3):399–408.PubMedGoogle Scholar
  84. 84.
    Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med. 2004;351(25):2611–8.PubMedCrossRefGoogle Scholar
  85. 85.
    Studahl M. Influenza virus and CNS manifestations. J Clin Virol. 2003;28(3):225–32.PubMedCrossRefGoogle Scholar
  86. 86.
    Takanashi J. Two newly proposed infectious encephalitis/encephalopathy syndromes. Brain Dev. 2009;31(7):521–8.PubMedCrossRefGoogle Scholar
  87. 87.
    Takanashi J, Tada H, Kuroki H, Barkovich AJ. Delirious behavior in influenza is associated with a reversible splenial lesion. Brain Dev. 2009;31(6):423–6.PubMedCrossRefGoogle Scholar
  88. 88.
    Takanashi J, Tsuji M, Amemiya K, Tada H, Barkovich AJ. Mild influenza encephalopathy with biphasic seizures and late reduced diffusion. J Neurol Sci. 2007;256(1–2):86–9.PubMedCrossRefGoogle Scholar
  89. 89.
    Tokuhira N, Shime N, Inoue M, et al. Mechanically ventilated children with 2009 pandemic influenza A/H1N1: results from the National Pediatric Intensive Care Registry in Japan. Pediatr Crit Care Med. 2012;13(5):e294–8.PubMedCrossRefGoogle Scholar
  90. 90.
    Tsuji M, Yoshida T, Miyakoshi C, Haruta T. Is a reversible splenial lesion a sign of encephalopathy? Pediatr Neurol. 2009;41(2):143–5.PubMedCrossRefGoogle Scholar
  91. 91.
    van der Vries E, Stelma FF, Boucher CA. Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus. N Engl J Med. 2010;363(14):1381–2.PubMedCrossRefGoogle Scholar
  92. 92.
    Vellozzi C, Broder KR, Haber P, Guh A, Nguyen M, Cano M, Lewis P, McNeil MM, Bryant M, Singleton J, et al. Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010. Vaccine. 2010;28(45):7248–55.PubMedCrossRefGoogle Scholar
  93. 93.
    Watanabe T, Okazaki E, Shibuya H. Influenza A virus-associated encephalopathy with haemophagocytic syndrome. Eur J Pediatr. 2003;162(11):799–800.PubMedCrossRefGoogle Scholar
  94. 94.
    Yamanouchi H, Kawaguchi N, Mori M, Imataka G, Yamagata T, Hashimoto T, Momoi MY, Eguchi M, Mizuguchi M. Acute infantile encephalopathy predominantly affecting the frontal lobes. Pediatr Neurol. 2006;34(2):93–100.PubMedCrossRefGoogle Scholar
  95. 95.
    Yamanouchi H, Mizuguchi M. Acute infantile encephalopathy predominantly affecting the frontal lobes (AIEF): a novel clinical category and its tentative diagnostic criteria. Epilepsy Res. 2006;70(Suppl 1):S263–8.PubMedCrossRefGoogle Scholar
  96. 96.
    Yang J, Wang Y-G, Xu Y-L, Ren X-L, Mao Y, Li X-W. A (H1N1) Influenza Pneumonia with Acute Disseminated Encephalomyelitis: a Case Report. Biomed Environ Sci. 2010;23(4):323–6.PubMedCrossRefGoogle Scholar
  97. 97.
    Yao D, Mizuguchi H, Yamaguchi M, Yamada H, Chida J, Shikata K, Kido H. Thermal instability of compound variants of carnitine palmitoyltransferase II and impaired mitochondrial fuel utilization in influenza-associated encephalopathy. Hum Mutat. 2008;29(5):718–27.PubMedCrossRefGoogle Scholar
  98. 98.
    Yokota S, Imagawa T, Miyamae T, Ito S, Nakajima S, Nezu A, Mori M. Hypothetical pathophysiology of acute encephalopathy and encephalitis related to influenza virus infection and hypothermia therapy. Pediatr Int. 2000;42(2):197–203.PubMedCrossRefGoogle Scholar
  99. 99.
    Zinman L, Thoma J, Kwong JC, Kopp A, Stukel TA, Juurlink DN. Safety of influenza vaccination in patients with myasthenia gravis: a population-based study. Muscle Nerve. 2009;40(6):947–51.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  1. 1.Department of Medicine, Division of NeurologyUniversity of TorontoTorontoCanada
  2. 2.Departments of Critical Care and Anesthesia, St. Michael’s HospitalUniversity of TorontoTorontoCanada
  3. 3.Department of Anesthesia and Inter-Departmental Division of Critical CareUniversity of TorontoTorontoCanada

Personalised recommendations